Biotech · Private company · Hillsborough, NC, US
Merakris Therapeutics
Track this companyFree. Adds Merakris Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- MTX-001 (human amniotic fluid)Phase 2 · Venous Stasis UlcerClinicalTrials.gov · fetched Nov 12, 2026
- MTX-001 (Dermacyte Liquid)Cutaneous UlcerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- MTX-001 for the Treatment of Non-Healing Venous Stasis UlcersPHASE2 · RECRUITING · started Feb 26, 2022ClinicalTrials.gov NCT04647240 · fetched Nov 12, 2026
- Dermacyte® Liquid for Treatment of Cutaneous Ulcers and WoundsAVAILABLEClinicalTrials.gov NCT06730022 · fetched Nov 12, 2026
NIH awards1
- Evaluation of Efficacy and Safety of MTX-001 in Diabetic Foot UlcersFiscal year 2026 · $1.1MNIH RePORTER 1R44DK146625-01 · fetched Nov 12, 2026